Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD103 blockade impair anti-CTLA-4 immunotherapy in oral cancer.

Oral oncology - 1 Mar 2023

Xiao Yao, Mao Liang, Yang Qi-Chao, Wang Shuo, Wu Zhi-Zhong, Wan Shu-Cheng, Zhang Meng-Jie, Sun Zhi-Jun

Abstract excerpt

OBJECTIVES: CD103+CD8+T cells is a subtype of T cells with excellent tumor killing ability and it could response to immune checkpoint blockade therapy in several types of cancer, but the phenotype, role and molecular mechanism CD103+CD8+T cells in the OSCC still unclear. MATERIALS AND METHODS: The distribution and phenotype of CD103+CD8+T cells were investigated by performing multiplexed immunohistochemistry on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD8-Positive T-Lymphocytes
Share to Immune Checkpoint Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Lymphocytes, Tumor-Infiltrating

Share to Mouth Neoplasms

Share to Phenotype

Source

Identifiers

PMID: 36753904
DOI: 10.1016/j.oraloncology.2023.106331

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD103 blockade impair anti-CTLA-4 immunotherapy in oral cancer.PMID 36753904Read ↗

Expansion of CD4+ cytotoxic T lymphocytes with specific gene expression patterns may contribute to suppression of tumor immunity in oral squamous cell carcinoma: single-cell analysis and in vitro experimentsSemantic proximity Read ↗

Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103+CD8+ T cells conferring favourable prognosisSemantic proximity Read ↗

CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma.Semantic proximity Read ↗

Distribution, phenotype, functional and clinical relevance of CD8+CD103+ tissue-resident memory T cells in human gastric cancer.Semantic proximity Read ↗

Tissue-resident memory CD8+ T cells in cancer immunology and immunotherapy.Semantic proximity Read ↗

Self-Maintaining CD103+ Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector ResponsesSemantic proximity Read ↗

Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade.Semantic proximity Read ↗

Phenotypic Differences of CD103+ Tissue-Resident Memory T Cells Associated with Various Cancers.Semantic proximity Read ↗

Regorafenib enhances antitumor immune efficacy of anti-PD-L1 immunotherapy on oral squamous cell carcinoma.Semantic proximity Read ↗

Association between CD103 and E-cadherin Immunoexpression with Pelvic Lymph Node Metastasis in Cervical Squamous Cell CarcinomaSemantic proximity Read ↗

Tissue-resident memory T cells play a key role in the efficacy of cancer vaccinesSemantic proximity Read ↗

Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.